Posts

Global Hair Loss Medications Market

Global Hair Loss Medications Market

/in /by

Global Hair Loss Medications Market 2018-2025

MarketInsights.biz added fresh and detailed market study report that focuses on “Global Hair Loss Medications Market 2018” offers essential concept into global Hair Loss Medications industry along with unique market insights, current top Manufactures in Hair Loss Medications industry, growth, challenges, subjects wise investigation of each chapters and approaching industry trends, which will help the customers to aim Hair Loss Medications market. In addition, the report help the clients to see specifications of products and driving the long-term income and productivity of global market.

This report studies the global Hair Loss Medications market status and forecast, categorizes the global Hair Loss Medications market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Hair Loss Medications market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

Merck
Johnson & Johnson
Gerolymatos International
Nanogen
Oxford BioLabs
Ultrax Labs
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Keranique
DS Healthcare Group

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Rx
OTC

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Male
Female
Both

The study objectives of this report are:

To analyze and study the global Hair Loss Medications sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Hair Loss Medications manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hair Loss Medications are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Hair Loss Medications Manufacturers
Hair Loss Medications Distributors/Traders/Wholesalers
Hair Loss Medications Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Hair Loss Medications market, by end-use.
Detailed analysis and profiles of additional market players.

Global Hair Loss Medications Market 2018-2025

Source

 

Previous Posts

Global Hair Loss Medications Market

Global Hair Loss Medications Market

/in /by

Global Hair Loss Medications Market 2018-2025

MarketInsights.biz added fresh and detailed market study report that focuses on “Global Hair Loss Medications Market 2018” offers essential concept into global Hair Loss Medications industry along with unique market insights, current top Manufactures in Hair Loss Medications industry, growth, challenges, subjects wise investigation of each chapters and approaching industry trends, which will help the customers to aim Hair Loss Medications market. In addition, the report help the clients to see specifications of products and driving the long-term income and productivity of global market.

This report studies the global Hair Loss Medications market status and forecast, categorizes the global Hair Loss Medications market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Hair Loss Medications market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

Merck
Johnson & Johnson
Gerolymatos International
Nanogen
Oxford BioLabs
Ultrax Labs
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Keranique
DS Healthcare Group

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Rx
OTC

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Male
Female
Both

The study objectives of this report are:

To analyze and study the global Hair Loss Medications sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Hair Loss Medications manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hair Loss Medications are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Hair Loss Medications Manufacturers
Hair Loss Medications Distributors/Traders/Wholesalers
Hair Loss Medications Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Hair Loss Medications market, by end-use.
Detailed analysis and profiles of additional market players.

Global Hair Loss Medications Market 2018-2025

Source

 

Previous Posts

Shinyak’s Rogain Foam

Competition heats up in hair loss treatment market

/in /by

Competition heats up in hair loss treatment market

Local drugmakers are increasingly competing to sell over-the-counter (OTC) drugs for hair loss treatments.

Dongkook Pharm’s Pansidil and Hyundai Pharm’s Minoxyl have been leading the market. However, three other rivals recently joined the competition with new products. They are JW Shinyak, Tai Guk Pharm, and Dong-A Pharm.

The market leader, Dongkook’s Pansidil, posted more than 6.5 billion won ($6.1 million) in accumulated sales as of the third quarter last year. The accrued ales of Hyundai Pharm’s Minoxyl stood at more than 4 billion won, leading the liquid OTC drugs.

Competition heats up in hair loss treatment market

JW Shinyak and Tai Guk Pharm aim to beat Hyundai with Minoxyl-containing products, and Dong-A, to overpower Dongkook with oral drugs.

JW Shinyak’s Rogain, an original product using Minoxidil, is likely to compete with Hyundai Pharm’s Minoxyl. For Rogain, JW Shinyak recently had an exclusive sales deal. Despite the launch in 2006, the drug sales have been sluggish due to Minoxyl’s outperformance.

JW Shinyak is seeking a turnaround by transforming the liquid of the product into a foam, improving the inconvenience that the liquid flows down to the forehead.

The user can apply the foam only in the necessary parts without the liquid falling to the face. The foam is absorbed into the scalp and dries quickly, which distinguishes it from rivals, the company said.

Tai Guk Pharm released Mobarin Gel, a gel-type product containing Minoxidil.

Like the foam-type one, the user can apply the gel directly on the scalp, and there is almost zero stickiness, Tai Guk Pharm said.

Mobarin is also easy to carry because it comes in a tube. The product comes in two versions, for female and for male, which is a strong point, the company said.

Dong-A Pharm’s Capillus capsule uses the same ingredient with Pansidil, the market leader. Capillus contains calcium pantothenate, keratin, L-cystine and double yeast. However, its efficacy and number of doses are the same with Pansidil.

The number of hair loss patients increased to 212,916 in 2016 from 203, 305 in 2012, according to the Health Insurance Review & Assessment Service (HIRA).

By age groups, hair loss was most common in people in their 30s, with 26.9 percent of them having a hair loss problem. People in their 20s came next with 25.4 percent having a hair loss, followed by those in their 40s with 23 percent.

Prescription drugs to treat hair loss include pinasteride and dutasteride.

However, people prefer OTC drugs due to concerns about adverse effects of prescription drugs such as sexual dysfunction in men and development of a deformed child in pregnant women.

Source

hair loss product research

Hair Loss & Growth Treatments and Products Market

/in /by

Global Hair Loss & Growth Treatments and Products Market Report Analysis (Years 2011-2017) and Market Forecast (Years 2018-2023)

Global Hair Loss & Growth Treatments and Products market research report highlights vital frameworks of Hair Loss & Growth Treatments and Products industry that includes market favourable circumstances, objectives, tendencies, drivers, and concerns.

It also throws a light on growth rate, current and fresh news of the Hair Loss & Growth Treatments and Products market along with different crucial industrial developments, top leading Hair Loss & Growth Treatments and Products industry players, and product modernization.

Global Hair Loss & Growth Treatments and Products report covers different provisions and regions and gives the market share of Hair Loss & Growth Treatments and Products industry covering each region. Correlation between the current market tendencies and competing regions along with leading market players are covered in the Hair Loss & Growth Treatments and Products report.

Different challenging market segments of Hair Loss & Growth Treatments and Products industry are also highlighted in the report.

The report titled ‘Global Hair Loss & Growth Treatments and Products market’ quotes out basic propulsive enforcements of the Hair Loss & Growth Treatments and Products industry that will be fruitful for the end-users.

Different business patterns, cautions, and the sector structures, its purchasing benchmarks and adversities faced are also cited in the Hair Loss & Growth Treatments and Products research report.

Further, it covers the scope of the Hair Loss & Growth Treatments and Products industry, its magnitude, and application in different areas. The overall revenue produced all over the globe and division of basic products according to their types determines the entire market size of the Hair Loss & Growth Treatments and Products industry.

Global Hair Loss & Growth Treatments and Products market is principally divided into dominant marketing players, applications, product types, and leading geographical zones. Vital company details such as company profiles, product specifications, price and sale of the product, product description, and contact information of also mentioned in the report.

Hair Loss & Growth Treatments and Products market separation on the basis of geographical zones:

The Hair Loss & Growth Treatments and Products market is escalated over the globe which includes Latin America (Middle and Africa), North America (Mexico, Canada, and the USA), Asia-Pacific (Korea, Japan, China and India). Asia-Pacific countries such as India and China will show advancement in the Hair Loss & Growth Treatments and Products market thus increasing the number of job opportunities.

North America has shown a tremendous increase and technological expansion in Hair Loss & Growth Treatments and Products industry over last few decades. Other European countries including Russia, France, Germany, Italy and the UK is also covered in the Hair Loss & Growth Treatments and Products market research report.

Global Hair Loss & Growth Treatments and Products market Company Coverage (Main Products,Price, Sales Revenue, Gross Margin):

Procter & Gamble
LOreal
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Yanagiya
Pharma Medico
Kerafiber
Phyto
Keranique
DS Healthcare Group
EcoHerbs Global
Kaminomoto
Softto
Bawang
Zhang Guang 101

Source